Ndjeka NO - Search Results

1

Tuberculosis testing patterns in South Africa to identify groups that would benefit from increased investigation.

Shapiro AN, Scott L, Moultrie H, Jacobson KR, Bor J, Fofana AM, Dor G, Ndjeka NO, da Silva P, Mlisana K, Jenkins HE, Stevens WS. Shapiro AN, et al. Among authors: ndjeka no. Sci Rep. 2023 Nov 27;13(1):20875. doi: 10.1038/s41598-023-47148-y. Sci Rep. 2023. PMID: 38012266 Free PMC article.

2

Xpert MTB/RIF versus sputum microscopy as the initial diagnostic test for tuberculosis: a cluster-randomised trial embedded in South African roll-out of Xpert MTB/RIF.

Churchyard GJ, Stevens WS, Mametja LD, McCarthy KM, Chihota V, Nicol MP, Erasmus LK, Ndjeka NO, Mvusi L, Vassall A, Sinanovic E, Cox HS, Dye C, Grant AD, Fielding KL. Churchyard GJ, et al. Among authors: ndjeka no. Lancet Glob Health. 2015 Aug;3(8):e450-e457. doi: 10.1016/S2214-109X(15)00100-X. Lancet Glob Health. 2015. PMID: 26187490 Free article. Clinical Trial.

3

Delays and loss to follow-up before treatment of drug-resistant tuberculosis following implementation of Xpert MTB/RIF in South Africa: A retrospective cohort study.

Cox H, Dickson-Hall L, Ndjeka N, Van't Hoog A, Grant A, Cobelens F, Stevens W, Nicol M. Cox H, et al. PLoS Med. 2017 Feb 21;14(2):e1002238. doi: 10.1371/journal.pmed.1002238. eCollection 2017 Feb. PLoS Med. 2017. PMID: 28222095 Free PMC article.

4

Multidrug-resistant tuberculosis outbreak in South Africa.

Ismail NA, McCarthy K, Conradie F, Stevens W, Ndjeka N. Ismail NA, et al. Lancet Infect Dis. 2019 Feb;19(2):134-135. doi: 10.1016/S1473-3099(18)30715-1. Epub 2018 Dec 6. Lancet Infect Dis. 2019. PMID: 30528116 No abstract available.

5

Evaluation of miLINC to shorten time to treatment for rifampicin-resistant Mycobacterium tuberculosis.

Farley JE, McKenzie-White J, Bollinger R, Hong H, Lowensen K, Chang LW, Stamper P, Berrie L, Olsen F, Isherwood L, Ndjeka N, Stevens W. Farley JE, et al. Int J Tuberc Lung Dis. 2019 Sep 1;23(9):980-988. doi: 10.5588/ijtld.18.0503. Int J Tuberc Lung Dis. 2019. PMID: 31615604

6

Assessment of epidemiological and genetic characteristics and clinical outcomes of resistance to bedaquiline in patients treated for rifampicin-resistant tuberculosis: a cross-sectional and longitudinal study.

Ismail NA, Omar SV, Moultrie H, Bhyat Z, Conradie F, Enwerem M, Ferreira H, Hughes J, Joseph L, Kock Y, Letsaolo V, Maartens G, Meintjes G, Ngcamu D, Okozi N, Padanilam X, Reuter A, Romero R, Schaaf S, Te Riele J, Variava E, van der Meulen M, Ismail F, Ndjeka N. Ismail NA, et al. Lancet Infect Dis. 2022 Apr;22(4):496-506. doi: 10.1016/S1473-3099(21)00470-9. Epub 2021 Nov 12. Lancet Infect Dis. 2022. PMID: 34780706

7

Organisation of care for people receiving drug-resistant tuberculosis treatment in South Africa: a mixed methods study.

Dickson L, Le Roux SR, Mitrani L, Hill J, Jassat W, Cox H, Mlisana K, Black J, Loveday M, Grant A, Kielmann K, Ndjeka N, Moshabela M, Nicol M. Dickson L, et al. BMJ Open. 2023 Nov 17;13(11):e067121. doi: 10.1136/bmjopen-2022-067121. BMJ Open. 2023. PMID: 37977868 Free PMC article.

8

Impact of reduced hospitalisation on the cost of treatment for drug-resistant tuberculosis in South Africa.

Sinanovic E, Ramma L, Vassall A, Azevedo V, Wilkinson L, Ndjeka N, McCarthy K, Churchyard G, Cox H. Sinanovic E, et al. Int J Tuberc Lung Dis. 2015 Feb;19(2):172-8. doi: 10.5588/ijtld.14.0421. Int J Tuberc Lung Dis. 2015. PMID: 25574915 Free PMC article.

9

Epidemiology of drug-resistant tuberculosis among children and adolescents in South Africa, 2005-2010.

Moore BK, Anyalechi E, van der Walt M, Smith S, Erasmus L, Lancaster J, Morris S, Ndjeka N, Ershova J, Ismail N, Burton D, Menzies H. Moore BK, et al. Int J Tuberc Lung Dis. 2015 Jun;19(6):663-9. doi: 10.5588/ijtld.14.0879. Int J Tuberc Lung Dis. 2015. PMID: 25946356 Free PMC article.

10

Persistently high early mortality despite rapid diagnostics for drug-resistant tuberculosis cases in South Africa.

Schnippel K, Firnhaber C, Ndjeka N, Conradie F, Page-Shipp L, Berhanu R, Sinanovic E. Schnippel K, et al. Int J Tuberc Lung Dis. 2017 Oct 1;21(10):1106-1111. doi: 10.5588/ijtld.17.0202. Int J Tuberc Lung Dis. 2017. PMID: 28911353

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters